The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
Abstract
Peganum harmala L. is a multipurpose medicinal plant increasingly used for psychoactive recreational purposes (Ayahuasca analog). Harmaline, harmine, harmalol, harmol and tetrahydroharmine were identified and quantified as the main beta-carboline alkaloids in P. harmala extracts. Seeds and roots contained the highest levels of alkaloids with low levels in stems and leaves, and absence in flowers. Harmine and harmaline accumulated in dry seeds at 4.3% and 5.6% (w/w), respectively, harmalol at 0.6%, and tetrahydroharmine at 0.1% (w/w). Roots contained harmine and harmol with 2.0% and 1.4% (w/w), respectively. Seed extracts were potent reversible and competitive inhibitors of human monoamine oxidase (MAO-A) with an IC(50) of 27 microg/l whereas root extracts strongly inhibited MAO-A with an IC(50) of 159 microg/l. In contrast, they were poor inhibitors of MAO-B. Inhibition of MAO-A by seed extracts was quantitatively attributed to harmaline and harmine whereas inhibition by root extracts came from harmine with no additional interferences. Stems and leaves extracts were poor inhibitors of MAO. The potent inhibition of MAO-A by seed and root extracts of P. harmala containing beta-carbolines should contribute to the psychopharmacological and toxicological effects of this plant and could be the basis for its purported antidepressant actions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here we address the other important active agents of ayahuasca, the β-carboline alkaloids, which act as selective, reversible MAO-A inhibitors (McKenna and Towers, 1984; dos Santos, 2010) with almost no effect on MAO-B (Herraiz et al., 2010).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Herraiz et al., 2010
Citations
Cites
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,235
Clinical Pharmacology of MAO Inhibitors: Safety and Future
Yamada, M. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00097-4 · Cited by 325
McKenna, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.03.002 · Cited by 321
Pharmacokinetics of Hoasca alkaloids in healthy humans
Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., Andrade, E. O., Andrade, E. O., & Mash, D. C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00168-8 · Cited by 318
Herraiz, T., & Chaparro, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.033 · Cited by 258
Inhibition of Monoamine Oxidase A by β-Carboline Derivatives
Kim, H., Sablin, S. O., & Ramsay, R. R. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9771 · Cited by 252
Monoamine oxidase and cigarette smoking
Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(02)00109-2 · Cited by 251
Farouk, L., Laroubi, A., Aboufatima, R., Ahmed Benharref, A., & Chait, A. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.014 · Cited by 188
Kartal, M., Altun, M. L., & Kurucu, S. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00568-x · Cited by 181
Flagged first, then by citations
1 of the 59 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Airaksinen, 1981, β-Carbolines, psychoactive compounds in the mammalian body. 2. Effects, Med. Biol., 59, 190
- Ben Salah, 1986, Aspects cliniques, pharmacologiques et toxicologiques du surdosage par une plante medicinale: le harmel, Essaydali Scientifique, 21, 13
- Kusmenoglu, 1996, The plant Peganum harmala L. and its biologically active constitutents, FABAD J. Pharm. Sci., 21, 71
- McKenna, 1998, The sciencific investigation of Ayahuasca: a review of past and current research, Heffter Rev. Psychedelic Res., 1, 65
Cited by
Sorted by citations
Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids
Moloudizargari, M., Mikaili, P., Aghajanshakeri, S., Asghari, M. H., & Shayegh, J. (2013) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/0973-7847.120524 · Cited by 384
“harmala has been used among societies to treat some nervous system disorders such as Parkinson`s disease,[19] in psychiatric conditions[7] such as nervosity,[20] and to relieve rigorous pain.”
BackgroundInfluentialPatel, K., Gadewar, M. M., Tripathi, R. K. P., Prasad, S., & Patel, D. K. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60116-6 · Cited by 267
The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization
Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242
“Here we address the other important active agents of ayahuasca, the β-carboline alkaloids, which act as selective, reversible MAO-A inhibitors (McKenna and Towers, 1984; dos Santos, 2010) with almost no effect on MAO-B (Herraiz et al., 2010).”
BackgroundAyahuasca: pharmacology, neuroscience and therapeutic potential
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.002 · Cited by 226
“In humans, they can reversibly block the activity of subtype A of the monoamine-oxidase (MAO) enzyme (Undenfriend et al., 1958; Buckholtz and Boggan, 1977a, Wang et al., 2010; Herraiz et al., 2010).”
BackgroundDai, J., Dan, W., Schneider, U., & Wang, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.027 · Cited by 181
Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. B. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180125095902 · Cited by 201
Frost, D., Meechoovet, B., Wang, T., Gately, S. T., Giorgetti, M., Shcherbakova, I. M., & Dunckley, T. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019264 · Cited by 177
Shen, H.-W., Jiang, X.-L., C. Winter, J., & Yu, A.-M. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233495 · Cited by 170
“, harmaline) [4, 32, 33], often leads to an enhanced and prolonged drug effect or more severe toxicity.”
Chemistry, pharmacology and medicinal properties of Peganum harmala L.
Asgarpanah, J. (2012) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp11.876 · Cited by 148
“Roots contain harmine and harmol with 2.0 and 1.4% (w/w), respectively (Herraiz et al., 2010).”
BackgroundInfluentialLi, S., Cheng, X. M., & Wang, C. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.03.049 · Cited by 141
Li, S.-P., Wang, Y., Qi, S., Zhang, Y., Deng, G., Ding, W.-Z., Ma, C., Lin, Q., Guan, H., Liu, W., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00346 · Cited by 134
“…of various neurotransmitters then may lead to biochemical, physiological, and behavioral changes in animals and human beings (Mahmoudian et al., 2002; Frison et al., 2008; Jiménez et al., 2008; Herraiz et al., 2010; Louis et al., 2010; Bensalem et al., 2014; Wang et al., 2015; Li et al., 2017a).”
BackgroundA Review of Hepatoprotective Plants Used in Saudi Traditional Medicine
Alasmari, A., Elaiwi, A. M. A., Athar, M. T., Tariq, M., Eid, A. A., & Al-Asmary, S. M. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/890842 · Cited by 122
Niroumand, M. C., Farzaei, M. H., & Amin, G. (2015) · 中医杂志:英文版 · doi:10.1016/s0254-6272(15)30016-9 · Cited by 118
Acute biphasic effects of ayahuasca.
Schenberg, E. E., Alexandre, J. F. M., Filev, R., Cravo, A. M., Sato, J. R., Muthukumaraswamy, S. D., Yonamine, M., Waguespack, M., Lomnicka, I., Barker, S. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137202 · Cited by 111
“This is in agreement with nausea being a common effect after ingestion of Peganum harmala, which contains high concentrations of harmaline [83].”
BackgroundFahmy, S. A., Fawzy, I. M., Saleh, B. M., Issa, M. Y., Bakowsky, U., & Azzazy, H. M. E.-S. (2021) · Nanomaterials · doi:10.3390/nano11040965 · Cited by 102
“harmala possess a broad spectrum of biological molecules which have antimicrobial, antioxidant, and anticancer activities [17,19].”
BackgroundCorrosion Inhibition Using Harmal Leaf Extract as an Eco-Friendly Corrosion Inhibitor
Otaibi, N. A., & Hammud, H. H. (2021) · Molecules · doi:10.3390/molecules26227024 · Cited by 100
“The constituents of Harmal extract are shown in Figure 1, [38].”
BackgroundInfluentialAli, S. K., Hamed, A. R., Soltan, M. M., Hegazy, U. M., Elgorashi, E. E., El-Garf, I. A., & Hussein, A. A. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-121 · Cited by 91
“harmala is a common dihydro β-carboline type, it possess interesting pharmacological activities and can interact with several enzymes and neurotransmittors including topoisomerase I, and monoamine oxidase-A [25,26].”
BackgroundLing, Y., Xu, C., Luo, L., Cao, J., Feng, J., Xue, Y., Zhu, Q., Ju, C., Li, F., Zhang, Y., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01052 · Cited by 91
Hydroxyl radical reactions and the radical scavenging activity of β-carboline alkaloids
Herraiz, T., & Galisteo, J. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.09.091 · Cited by 84
Herraiz, T., & Guillén, H. (2018) · BioMed Research International · doi:10.1155/2018/4810394 · Cited by 82
“Peganum harmala (family Zygophyllaceae) and Lepidiummeyenii (family Brassicaceae) (maca) are plants with CNS effects and potential antidepressant actions [14, 25, 26].”
BackgroundMethodInfluentialChaurasiya, N. D., León, F., Muhammad, I., & Tekwani, B. L. (2022) · Molecules · doi:10.3390/molecules27134297 · Cited by 86
Bharadwaj, P. R., Bates, K. A., Porter, T., Teimouri, E., Perry, G. L., Steele, J., Gandy, S., Groth, D., Martins, R. N., & Verdile, G. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.97 · Cited by 81
6-Hydroxydopamine: a far from simple neurotoxin
Varešlija, D., Tipton, K. F., Davey, G. P., & McDonald, A. G. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-019-02133-6 · Cited by 80
TLC‐SERS study of Syrian rue (Peganum harmala) and its main alkaloid constituents
Pozzi, F., Shibayama, N., Leona, M., & Lombardi, J. R. (2012) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4140 · Cited by 77
Karous, O., Jilani, I. B. H., & Ghrabi‐Gammar, Z. (2021) · Plants · doi:10.3390/plants10040642 · Cited by 71
Antioxidant and Anti-Inflammatory Effects of Peganum harmala Extracts: An In Vitro and In Vivo Study
Abbas, M. W., Hussain, M., Qamar, M., Ali, S., Shafiq, Z., Wilairatana, P., & Mubarak, M. S. (2021) · Molecules · doi:10.3390/molecules26196084 · Cited by 69
Drug–drug interactions involving classic psychedelics: A systematic review
Halman, A., Kong, G., Sarris, J. J., & Perkins, D. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231211219 · Cited by 78
“However, considering the tiny weight (Li et al., 2023) and the average content of alkaloids in these seeds (Herraiz et al., 2010), the estimated total harmaline and harmine content would be only approximately 0.26 mg and 0.34 mg, respectively.”
BackgroundInfluentialGene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Josset, L., Textoris, J., Loriod, B., Ferraris, O., Moulés, V., Lina, B., Nguyen, C., Diaz, J., & Rosa‐Calatrava, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013169 · Cited by 72
Chaurasiya, N. D., Ibrahim, M. A., Muhammad, I., Walker, L., & Tekwani, B. L. (2014) · Molecules · doi:10.3390/molecules191118936 · Cited by 68
“Herbal natural products have been suggested as important source for inhibitors of MAOs and also support traditional use of these herbal products as alternative for treatment of depression, Parkinson’s disease and other neuropsychiatric as well as neurological disorders [19] Specially, the dietary supplements and herba…”
BackgroundYang, Y., Cheng, X. M., Liu, W., Chou, G., Wang, Z., & Wang, C. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.03.070 · Cited by 69
“It was determined that the total alkaloids content (mainly harmine and harmaline) in dry seeds of P. harmala could accumulated up to 4.3% and 5.6% (w/w) (Herraiza et al., 2010; Wang et al., 2002).”
BackgroundInfluentialRole of the modulation of CYP1A1 expression and activity in chemoprevention
Badal, S., & Delgoda, R. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.2968 · Cited by 63
“, 2012) naturally found in several medicinal plants including Peganum harmala (Zygophyllaceae) and Banisteriopsis Caapi (Malpighiaceae) (Herraiz et al., 2010; Samoylenko et al., 2010).”
BackgroundWilliams, G. H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-12 · Cited by 64
“The ALS SOD1(G93A) profile correlation is only seen with late stage disease. breakdown of monoamine neurotransmitters through inhibition of monoamine oxidase A [56,57].”
BackgroundMain Alkaloids of Peganum harmala L. and Their Different Effects on Dicot and Monocot Crops
Shao, H., Huang, X., Zhang, Y., & Zhang, C. (2013) · Molecules · doi:10.3390/molecules18032623 · Cited by 64
Ayoob, I., Hazari, Y., Lone, S. H., Shakeel-u-Rehman, Khuroo, M. A., Fazili, K. M., & Bhat, K. A. (2017) · ChemistrySelect · doi:10.1002/slct.201700232 · Cited by 59
In vitro and in vivo activity of Peganum harmala L. alkaloids against phytopathogenic bacteria
Shaheen, H. A., & Issa, M. Y. (2019) · Scientia Horticulturae · doi:10.1016/j.scienta.2019.108940 · Cited by 58
“The seeds of P. harmala contain about 2 to 6% pharmacologically active alkaloids (Hilal and Youngken, 1983), including a number of β-carboline and quinazoline alkaloids, collectively known as harmala alkaloids.”
BackgroundDas, T., Saha, S. C., Kumari, S., Majumder, M., Ghorai, M., Mane, A. B., Prasanth, D. A., Kumar, P., Pandey, D. K., Al-Tawaha, A. R., et al. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.09.019 · Cited by 58
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
Alomar, M. L., Rasse‐Suriani, F. A. O., Ganuza, A., Cóceres, V. M., Cabrerizo, F. M., & Angel, S. O. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-193 · Cited by 57
Yamazaki, Y., & Kawano, Y. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.388 · Cited by 57
Cytotoxicity of alkaloids isolated from Peganum harmala seeds.
Lamchouri, F., Zemzami, M., Jössang, A., Abdellatif, A., Israili, Z. H., & Lyoussi, B. (2013) · PubMed · Cited by 56
Ayahuasca: Uses, Phytochemical and Biological Activities
Estrella-Parra, E. A., Almanza-Pérez, J. C., & Alarcón-Aguilar, F. J. (2019) · Natural Products and Bioprospecting · doi:10.1007/s13659-019-0210-5 · Cited by 61
Screening of Medicinal Plants from Iranian Traditional Medicine for Acetylcholinesterase Inhibition
Adhami, H., Farsam, H., & Krenn, L. (2011) · Phytotherapy Research · doi:10.1002/ptr.3409 · Cited by 55
“…has shown many biological activities for this drug such as antibacterial (Shahverdi et al., 2005), antifungal (Nenaah, 2010), MAO inhibitory (Herraiz et al., 2010), antinociceptive (Monsef et al., 2004), antiprotozoal (Arshad et al., 2008), antitumour (Li et al., 2007) and antioxidant…”
BackgroundHerbal Natural Products As a Source of Monoamine Oxidase Inhibitors: A Review
Viña, D., Serra, S., Lamela, M., & Delogu, G. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805219996 · Cited by 55
Dietary inhibitors of monoamine oxidase A
Clarke, S. E. D., & Ramsay, R. (2011) · Journal of neural transmission · doi:10.1007/s00702-010-0537-x · Cited by 51
“Harmine and harmaline are the active MAO inhibiting constituents of Peganum harmala, a multipurpose herbal remedy with psychopharmacological effects, so Peganum harmala may be useful as an antidepressant (Herraiz et al. 2010).”
BackgroundTang, S. R., Wang, J., Xiong, Z., Xie, Z., Li, D., Huang, J., & Zhu, Q. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b02725 · Cited by 55
Roy, S., Mohammad, T., Gupta, P., Dahiya, R., Parveen, S., Luqman, S., Hasan, G. M., & Hassan, M. I. (2020) · ACS Omega · doi:10.1021/acsomega.0c02165 · Cited by 54
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Lowe, H. I. C., Toyang, N. J., Steele, B., Grant, J., Ali, A., Gordon, L., & Ngwa, W. F. (2022) · Molecules · doi:10.3390/molecules27082520 · Cited by 58
“caapi-produced MAOIs [88,93], such as the beta-carboline harmine [80].”
BackgroundInfluentialReview on in-vitro anti-Malarial activity of Natural β-carboline Alkaloids
Ashok, P., Ganguly, S., & Murugesan, S. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511313120008 · Cited by 53
Pre-clinical investigations of β-carboline alkaloids as antidepressant agents: A systematic review
Ferraz, C. A. A., Júnior, R. G. D. O., Picot, L., Almeida, J. R. G. D. S., & Nunes, X. P. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104196 · Cited by 56
Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines
Manda, S., Khan, S. I., Jain, S. K., Mohammed, S., Tekwani, B. L., Khan, I. A., Vishwakarma, R. A., & Bharate, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.030 · Cited by 50
Yang, M.-L., Kuo, P., Hwang, T., Chiou, W.-F., Qian, K., Lai, C.-Y., Lee, K., & Wu, T.-S. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.034 · Cited by 50
Devi, N., Kumar, S., Pandey, S. K., & Singh, V. (2017) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.201700477 · Cited by 50
Apostolico, I., Aliberti, L., Caputo, L., Feo, V. D., Fratianni, F., Nazzaro, F., Souza, L. F., & Khadhr, M. (2016) · Molecules · doi:10.3390/molecules21091235 · Cited by 49
“The seeds are also a rich source of β-carboline alkaloids [9,10].”
BackgroundPsychoactive natural products: overview of recent developments.
Ujváry, I. (2014) · PubMed · doi:10.4415/ann_14_01_04 · Cited by 48
Xing, M., Shen, F., Liu, L., Chen, Z., Guo, N., Wang, X., Wang, W.-Y., Zhang, K., Wu, X., Wang, X., et al. (2012) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2012.03233.x · Cited by 47
“Furthermore, harmaline can interact with several enzymes and neurotransmitters including topoisomerase I, and monoamine oxidase-A (Sobhani et al. 2002; Herraiz et al. 2010).”
BackgroundCytotoxic quinazoline alkaloids from the seeds of Peganum harmala
Li, S.-G., Wang, K., Gong, C., Bao, Y. J., Qin, N., Li, D., Li, Z., Bai, J., & Hua, H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.003 · Cited by 47
Natural Products from Endophytic Fungi Associated with Rubiaceae Species
Cruz, J. S., da Silva, C. A., & Hamerski, L. (2020) · Journal of Fungi · doi:10.3390/jof6030128 · Cited by 47
Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease
Vrabec, R., Blunden, G., & Cahlíková, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054399 · Cited by 50
“microbial, antitumor, and antidiabetic potencies [70,92].”
BackgroundAli-Shtayeh, M. S., Jamous, R. M., Abu-Zaitoun, S. Y., & Qasem, I. B. (2014) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v4i9.149 · Cited by 46
“harmala, is a common dihydro β-carboline type; it possess interesting pharmacological activities and can interact with several enzymes and neurotransmitters including topoisomerase I, and monoamine oxidase-A [59, 60].”
BackgroundHarmine augments electrically evoked dopamine efflux in the nucleus accumbens shell
Brierley, D., & Davidson, C. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112463125 · Cited by 44
“This novel finding that harmine augments NAc DA efflux apparently independently of MAO-A inhibition is of relevance given the canonical classification of harmine as an inhibitor of MAO-A (Herraiz et al., 2010).”
BackgroundSwitch to mania after ayahuasca consumption in a man with bipolar disorder: a case report
Szmulewicz, A., Valerio, M. P., & Smith, J. M. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-014-0020-y · Cited by 45
Almadiy, A. A., Nenaah, G. E., & Shawer, D. (2017) · Journal of Pest Science · doi:10.1007/s10340-017-0924-2 · Cited by 45
“These β-carbolines can easily cross the blood–brain barrier altering the neurotransmitter concentrations, exerting a variety of neurophysiological and toxicological effects (Herraiz et al. 2010).”
BackgroundCosta‐Machado, L. F., García-Domínguez, E., McIntyre, R. L., López-Aceituno, J. L., Ballesteros-Gonzalez, Á., Tapia-Gonzalez, A., Fabregat‐Safont, D., Eisenberg, T., Gómez, J., Plaza, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38410-y · Cited by 47
“As a positive control, we used harmine, another β -carboline previously described as a pan-MAO inhibitor 41 that we also detected in our initial screen (Fig.”
Wu, L., Zhang, J., Rao, M., Zhang, Z., Zhu, H., & Zhang, C. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s205097 · Cited by 44
Improving health benefits with considering traditional and modern health benefits of Peganum harmala
Shahrajabian, M. H., Sun, W., & Cheng, Q. (2021) · Clinical Phytoscience · doi:10.1186/s40816-021-00255-7 · Cited by 44
Gendy, M. A. M. E., Soshilov, A. A., Denison, M. S., & El‐Kadi, A. O. S. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.10.052 · Cited by 44
“Harmaline and harmalol are common dihydro-β-carbolines that widely distributed in the environment including alcoholic beverages and several plants such as Peganum harmala (Zygophyllaceae) (Herraiz et al., 2010; Park et al., 2010).”
BackgroundInfluentialXu, J., Ao, Y., Huang, C., Song, X., Zhang, G., Cui, W., Wang, Y., Zhang, X., & Zhang, Z. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00361-4 · Cited by 43
Zhou, B., Liu, Z., Deng, G., Chen, W., Li, M., Yang, L., Li, Y., Yang, X., & Zhang, H. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01495j · Cited by 43
Herraiz, T., Flores, A., & Fernández, L. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.12.004 · Cited by 43
Ling, Y., Li, Y., Zhu, R., Qian, J., Liu, J., Gao, W., Meng, C., Miao, J., Xiong, B., Qiu, X., et al. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00843 · Cited by 43
González‐Ruiz, V., León, A. G., Olives, A. I., Martín, M. A., & Menéndez, J. C. (2010) · Green Chemistry · doi:10.1039/c0gc00456a · Cited by 43
Cytotoxic Indole Alkaloids against Human Leukemia Cell Lines from the Toxic Plant Peganum harmala
Wang, C., Zhang, Z., Wang, Y., & He, X. (2015) · Toxins · doi:10.3390/toxins7114507 · Cited by 42
“Recently, much research has revealed that β-carboline and quinazoline alkaloids are important ingredients, accounting for many of the pharmacological and therapeutic effects, such as analgesic [4], antibacterial [5], antiparasitic [6], strong reversible inhibition activity of monoamine oxidase [7], cytotoxic and antit…”
BackgroundJiang, B., Meng, L., Zou, N., Wang, H., Li, S., Huang, L., Cheng, X. M., Wang, Z., Chen, W., & Wang, C. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152967 · Cited by 42
Serdaroğlu, G. (2019) · Research on Chemical Intermediates · doi:10.1007/s11164-019-04020-x · Cited by 42
Drung, B., Scholz, C., Barbosa, V. A., Nazari, A., Sarragiotto, M. H., & Schmidt, B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.08.054 · Cited by 41
Munir, S., Shahid, A., Aslam, B., Ashfaq, U. A., Akash, M. S. H., Ali, M. A., Almatroudi, A., Allemailem, K. S., Rajoka, M. S. R., & Khurshid, M. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8836983 · Cited by 42
Nenaah, G. E. (2011) · Journal of Stored Products Research · doi:10.1016/j.jspr.2011.04.004 · Cited by 40
Santillo, M. F., Liu, Y., Ferguson, M. S., Vohra, S., & Wiesenfeld, P. L. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.006 · Cited by 38
Herraiz, T. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.08.009 · Cited by 39
Aziz, M. A., Adnan, M., Khan, A. H., Sufyan, M., & Khan, S. N. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.007 · Cited by 39
Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala
Herraiz, T., Guillén, H., Arán, V. J., & Salgado, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.03.010 · Cited by 38
Anticancer Potential of β‐Carboline Alkaloids: An Updated Mechanistic Overview
Tshikhudo, P. P., Mabhaudhi, T., Koorbanally, N. A., Mudau, F. N., Cáceres, E. A., Popa, D. G., Călina, D. C., & Sharifi‐Rad, J. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301263 · Cited by 37
Voltammetric determination of harmaline in natural food products using boron-doped diamond electrode
Švorc, Ĺ., Cinková, K., Samphao, A., Stanković, D. M., Mehmeti, E., & Kalcher, K. (2015) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2015.03.004 · Cited by 37
Ademiluyi, A. O., Ogunsuyi, O. B., Oboh, G., & Agbebi, O. J. (2016) · Comparative Clinical Pathology · doi:10.1007/s00580-016-2257-6 · Cited by 37
“Furthermore, plant extracts such as from Syrian rue (Peganum harmala) (Herraiz et al. 2010) and Passion flower (Passiflora incarnata) (Dhawan et al.”
BackgroundXu, Q., Chen, X., Feng, J., Miao, J., Liu, J., Liu, F.-T., Niu, B.-X., Cai, J., Huang, C., Zhang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep36238 · Cited by 37
Bona, E., Massa, N., Toumatia, O., Novello, G., Cesaro, P., Todeschini, V., Boatti, L., Mignone, F., Titouah, H., Zitouni, A., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9071359 · Cited by 37
Mennenga, S. E., Gerson, J. E., Dunckley, T. L., & Bimonte‐Nelson, H. A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.09.001 · Cited by 36
Yang, Y.-D., Cheng, X.-M., Liu, W., Han, Z.-Z., Chou, G., Wang, Y., Sun, D., Wang, Z., & Wang, C. (2016) · RSC Advances · doi:10.1039/c6ra00086j · Cited by 36
Herraiz, T., & Guillén, H. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.026 · Cited by 38
Evaluation of Antidiabetic and Antihyperlipidemic Effects of Peganum harmala Seeds in Diabetic Rats
Komeili, G., Hashemi, M. M., & Bameri-Niafar, M. (2016) · Cholesterol · doi:10.1155/2016/7389864 · Cited by 36
Lawson, M., Rodrigo, J., Baratte, B., Robert, T., Delehouzé, C., Lozach, O., Ruchaud, S., Bach, S., Brion, J., Alami, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.040 · Cited by 36
Alkaloids of Peganum harmala: Anticancer Biomarkers with Promising Outcomes
Jalali, A., Dabaghian, F., & Zarshenas, M. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201125103941 · Cited by 35
Antitumor quinazoline alkaloids from the seeds ofPeganum harmala
Wang, C., Zeng, H. M., Wang, Y.-H., Li, C., Cheng, J., Ye, Z.-J., & He, X. (2015) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2015.1042373 · Cited by 34
Afifi‐Yazar, F. Ü. (2013) · Scientia Pharmaceutica · doi:10.3797/scipharm.1212-20 · Cited by 34
“ACE-inhibitory activity [367, 368] and inhibition of human monoamine oxidase (MAO) [369].”
BackgroundGaujac, A., Navickiene, S., Collins, M. I., Brandt, S. D., & de Andrade, J. B. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1343 · Cited by 40
Guo, Y., Yu, J., Cao, Y., Cheng, K.-X., Suonanmu, D., Zhang, Y., Ren, Q., Yin, Y., & Li, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116061 · Cited by 33
Polanski, W. H., Reichmann, H., & Gille, G. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.1 · Cited by 33
Zhi, K., Yang, Z., Shi, D., Yao, X., & Wang, M.-G. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.07.022 · Cited by 33
“Monoamine oxidase (MAO) is a mitochondrial enzyme that catalyzes the oxidative deamination of biogenic amines and neurotransmitters [1].”
BackgroundAlkaloids as Potential Multi-Target Drugs to Treat Alzheimer's Disease
Lima, J. A., & Hamerski, L. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64183-0.00008-7 · Cited by 34
Sharifi‐Rad, J., Quispe, C., Herrera‐Bravo, J., Semwal, P., Painuli, S., Özçelik, B., Hacıhasanoğlu, F. E., Shaheen, S., Sen, S., Acharya, K., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5900422 · Cited by 33
Senhaji, S., Lamchouri, F., Boulfia, M., Lachkar, N., Bouabid, K., & Toufik, H. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2022.03.005 · Cited by 34
Metadata
- Authors
- Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Instituto de Química Médica (ES)
- Corresponding author
- Herraiz, T.
- Venue
- Food and Chemical Toxicology
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 48
- Issue
- 3
- Pages
- 839-845
- ISSN
- 0278-6915 (ISSN-L)
- OpenAlex
- W2169624105
- Cited by
- 357
- References
- 59
- Citations by year
- 2026: 31 · 2025: 24 · 2024: 16 · 2023: 25 · 2022: 27 · 2021: 25 · 2020: 26 · 2019: 26 · 2018: 18 · 2017: 19 · 2016: 21 · 2015: 18 · 2014: 23 · 2013: 23 · 2012: 12
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Food and Chemical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Spanish government (AGL2006-02414)
- CSIC (200470E658)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- Peganum harmala, β-carbolines, harmine, harmaline, harmol, tetrahydroharmine, harmalol, monoamine oxidase A inhibition, monoamine oxidase B inhibition, seeds, roots, antidepressant effects, psychopharmacology, toxicology
- MeSH terms
- Carbolines, Chromatography, High Pressure Liquid, Harmaline, Harmine, Humans, Kinetics, Monoamine Oxidase, Monoamine Oxidase Inhibitors, Plant Extracts, Seeds, Spectrophotometry, Ultraviolet, Plant Roots, Spectrometry, Mass, Electrospray Ionization, Peganum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review